ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ·Healthcare·Biotechnology
$22.76
+2.06%
Mkt Cap $3.74B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $292.79M | $283.99M | -3.00% | $0.14 | $1.60 | +1067.88% | — | — |
| Q4 2025 Nov 5, 2025 | $292.59M | $278.63M | -4.77% | $0.14 | $0.26 | +85.71% | — | — |
| Q3 2025 Aug 6, 2025 | $262.00M | $264.57M | +0.98% | $0.14 | $0.16 | +14.29% | — | — |
| Q2 2025 May 7, 2025 | $238.97M | $244.32M | +2.24% | $0.10 | $0.11 | +10.00% | — | — |
| Q1 2025 Feb 26, 2025 | $273.04M | $259.60M | -4.92% | $0.13 | $0.17 | +30.77% | — | — |
| Q4 2024 Nov 6, 2024 | $282.92M | $250.40M | -11.49% | $0.14 | $0.20 | +42.86% | — | — |
| Q3 2024 Aug 6, 2024 | $235.42M | $241.96M | +2.78% | $0.18 | $0.20 | +11.11% | — | — |
| Q2 2024 May 8, 2024 | $208.29M | $205.83M | -1.18% | $0.05 | $0.10 | +100.00% | — | — |
| Q1 2024 Feb 27, 2024 | $223.78M | $231.04M | +3.24% | $0.30 | $0.28 | -6.67% | — | — |
| Q4 2023 Nov 2, 2023 | $224.38M | $211.70M | -5.65% | -$0.43 | -$0.40 | +6.98% | — | — |
| Q3 2023 Aug 2, 2023 | $157.85M | $165.24M | +4.68% | -$0.12 | $0.01 | +108.33% | — | — |
| Q2 2023 May 8, 2023 | $120.08M | $118.46M | -1.35% | -$0.21 | -$0.27 | -28.57% | — | — |
| Q1 2023 Feb 27, 2023 | $134.23M | $136.49M | +1.68% | -$0.25 | -$0.26 | -4.00% | — | — |
| Q4 2022 Nov 2, 2022 | $138.76M | $130.71M | -5.80% | -$0.18 | -$0.17 | +5.56% | — | — |
| Q3 2022 Aug 8, 2022 | $130.41M | $134.56M | +3.19% | -$0.25 | -$0.21 | +16.00% | — | — |
| Q2 2022 May 4, 2022 | $121.91M | $115.47M | -5.29% | -$0.49 | -$0.70 | -42.86% | — | — |
| Q1 2022 Feb 28, 2022 | $135.39M | $130.76M | -3.42% | -$0.24 | -$0.27 | -12.50% | — | — |
| Q4 2021 Nov 8, 2021 | $135.38M | $131.61M | -2.78% | -$0.27 | -$0.09 | +66.67% | — | — |
| Q3 2021 Aug 4, 2021 | $115.22M | $115.22M | +0.00% | -$0.30 | -$0.27 | +10.00% | — | — |
| Q2 2021 May 5, 2021 | $110.22M | $106.55M | -3.33% | -$0.53 | -$0.42 | +20.75% | — | — |